Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-10

Clinical Trial Update: Daily Practice Treatment and Influence of Visanne on the Patient Assessment of Quality of Life

View source ↗

Summary

A completed clinical trial assessing daily practice treatment and the impact of Visanne (dienogest) on quality of life in endometriosis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Visanne (Dienogest)

Snippet

Sponsor: Bayer | Conditions: Endometriosis | Status: COMPLETED